Alcohol consumption promotes diethylnitrosamine-induced hepatocarcinogenesis in male mice through activation of the Wnt/β-catenin signaling pathway

Cancer Prevention Research

Volumn 7, Issue 7, 2014, Pages 675-685

  Mercer, Kelly E ^a,b   Hennings, Leah ^a   Sharma, Neha ^b   Lai, Keith ^a   Cleves, Mario A ^b   Wynne, Rebecca A ^b   Badger, Thomas M ^a,b   Ronis, Martin J J ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b U S DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BETA CATENIN; CYCLIN D1; DIETHYLNITROSAMINE; GLUTAMATE AMMONIA LIGASE; GLYCOGEN SYNTHASE KINASE 3BETA; MATRILYSIN; REGUCALCIN; RETINOL; TUMOR NECROSIS FACTOR ALPHA; WNT PROTEIN; WNT1 PROTEIN; WNT7A PROTEIN; ALKYLATING AGENT; AUTACOID; MESSENGER RNA;

ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSOL; GENE EXPRESSION; LIQUID CHROMATOGRAPHY; LIVER CARCINOGENESIS; LIVER CELL; LIVER FIBROSIS; MALE; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; TISSUE DIFFERENTIATION; TUMOR PROMOTION; UPREGULATION; WESTERN BLOTTING; WNT SIGNALING PATHWAY; ANIMAL; C57BL MOUSE; CARCINOGENESIS; CHEMICALLY INDUCED; DRINKING BEHAVIOR; DRUG EFFECTS; ENZYME IMMUNOASSAY; EXPERIMENTAL LIVER NEOPLASM; GENETICS; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TOXICITY;

ALCOHOL DRINKING; ALKYLATING AGENTS; ANIMALS; BLOTTING, WESTERN; CARCINOGENESIS; CELL PROLIFERATION; DIETHYLNITROSAMINE; IMMUNOENZYME TECHNIQUES; INFLAMMATION MEDIATORS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TANDEM MASS SPECTROMETRY; WNT SIGNALING PATHWAY;

EID: 84904350155     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-13-0444-T     Document Type: Article

References (51)

1. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009;27:1485-91.
2. Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002;36:1206-13. (Pubitemid 35253437)
3. Welzel TM, Graubard BI, Zeuzem S, El Serag HB, Davila JA, McGlynn KA. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology 2011;54:463-71.
4. Chen CJ, Liang KY, Chang AS, Chang YC, Lu SN, Liaw YF, et al. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology 1991; 13:398-406.
5. Mohamed AE, Kew MC, Groeneveld HT. Alcohol consumption as a risk factor for hepatocellular carcinoma in urban southern African Blacks. Int J Cancer 1992;51:537-41.
6. Poschl G, Seitz HK. Alcohol and cancer. Alcohol Alcohol 2004;39: 155-65. (Pubitemid 38578731)
7. Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology 2004;127:S87-96. (Pubitemid 39423374)
8. Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 2007;7:599-12.
9. Baumgardner JN, Shankar K, Korourian S, Badger TM, Ronis MJ. Undernutrition enhances alcohol-induced hepatocyte proliferation in the liver of rats fed via total enteral nutrition. Am J Physiol Gastrointest Liver Physiol 2007;293:G355-64. (Pubitemid 47105198)
10. Brandon-Warner E, Walling TL, Schrum LW, McKillop IH. Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis. Alcohol Clin Exp Res 2012;36:641-53.
11. Chung J, Liu C, Smith DE, Seitz HK, Russell RM, Wang XD. Restoration of retinoic acid concentration suppresses ethanol-enhanced c-Jun expression and hepatocyte proliferation in rat liver. Carcinogenesis 2001;22:1213-19. (Pubitemid 32737338)
12. Isayama F, Froh M, Yin M, Conzelmann LO, Milton RJ, McKim SE, et al. TNF alpha-induced Ras activation due to ethanol promotes hepatocyte proliferation independently of liver injury in the mouse. Hepatology 2004;39:721-31. (Pubitemid 38337651)
13. Ronis MJ, Butura A, Korourian S, Shankar K, Simpson P, Badeaux J, et al. Cytokine and chemokine expression associated with steatohepatitis and hepatocyte proliferation in rats fed ethanol via total enteral nutrition. Exp Biol Med 2008;233:344-55. (Pubitemid 351328576)
14. Ronis MJ, Hennings L, Stewart B, Basnakian AG, Apostolov EO, Albano E, et al. Effects of long-term ethanol administration in a rat total enteral nutrition model of alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 2011;300:G109-19.
15. Yip-Schneider MT, Doyle CJ, McKillop IH, Wentz SC, Brandon-Warner E, Matos JM, et al. Alcohol induces liver neoplasia in a novel alcohol-preferring rat model. Alcohol Clin Exp Res 2011;35:2216-25.
16. Yanagitani A, Yamada S, Yasui S, Shimomura T, Murai R, Murawaki Y, et al. Retinoic acid receptor alpha dominant negative form causes steatohepatitis and liver tumors in transgenic mice. Hepatology 2004;40:366-75. (Pubitemid 39062854)
17. Hennig M, Yip-Schneider MT, Klein P, Wentz S, Matos JM, Doyle C, et al. Ethanol-TGFalpha-MEK signaling promotes growth of human hepatocellular carcinoma. J Surg Res 2009;154:187-95.
18. Thoresen GH, Guren TK, Sandnes D, Peak M, Agius L, Christoffersen T. Response to transforming growth factor alpha (TGFalpha) and epidermal growth factor (EGF) in hepatocytes: lower EGF receptor af fi nity of TGFalpha is associated with more sustained activation of p42/p44 mitogen-activated protein kinase and greater efficacy in stimulation of DNA synthesis. J Cell Physiol 1998;175:10-18. (Pubitemid 28101967)
19. Calvisi DF, Ladu S, Factor VM, Thorgeirsson SS. Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGFalpha hepatocarcinogenesis promoted by phenobarbital. Carcinogenesis 2004;25:901-8. (Pubitemid 38886076)
20. Edamoto Y, Hara A, Biernat W, Terracciano L, Cathomas G, Riehle HM, et al. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis. Int J Cancer 2003;106:334-41. (Pubitemid 36870393)
21. Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 2006;43:515-24.
22. Nejak-Bowen KN, Monga SP. Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. Semin Cancer Biol 2011;21:44-58.
23. Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM. Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis 2007;27:55-76.
24. Mercer KE, Wynne RA, Lazarenko OP, Lumpkin CK, Hogue WR, Suva LJ, et al. Vitamin D supplementation protects against bone loss associated with chronic alcohol administration in female mice. J Pharmacol Exp Ther 2012;343:401-12.
25. Cardiff RD, Anver MR, Boivin GP, Bosenberg MW, Maronpot RR, Molinolo AA, et al. Precancer in mice: animal models used to understand, prevent, and treat human precancers. Toxicol Pathol 2006; 34:699-707. (Pubitemid 44665522)
26. Dillner L, Josefson D, Karcher H, Sheldon T, Dorozynski A, Zinn C. Alcohol- pushing the limits. BMJ 1996;312:7-9.
27. Crabb DW, Zeng Y, Liangpunsakul S, Jones R, Considine R. Ethanol impairs differentiation of human adipocyte stromal cells in culture. Alcohol Clin Exp Res 2011;35:1584-92.
28. Ronis MJ, Wands JR, Badger TM, de la Monte SM, Lang CH, Calissendorff J. Alcohol-induced disruption of endocrine signaling. Alcohol Clin Exp Res 2007;31:1269-85. (Pubitemid 47063129)
29. Abdelmegeed MA, Banerjee A, Yoo SH, Jang S, Gonzalez FJ, Song BJ. Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis. J Hepatol 2012;57:860-66.
30. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006;43:S99-12.
31. Tan X, Behari J, Cieply B, Michalopoulos GK, Monga SP. Conditional deletion of beta-catenin reveals its role in liver growth and regeneration. Gastroenterology 2006;131:1561-72. (Pubitemid 44708943)
32. Wang Y, Ausman LM, Greenberg AS, Russell RM, Wang XD. Nonalcoholic steatohepatitis induced by a high-fat diet promotes diethylni-trosamine- initiated early hepatocarcinogenesis in rats. Int J Cancer 2009;124:540-46.
33. He L, Marecki JC, Serrero G, Simmen FA, Ronis MJ, Badger TM. Dose-dependent effects of alcohol on insulin signaling: partial explanation for biphasic alcohol impact on human health.Mol Endocrinol 2007;21:2541-50. (Pubitemid 47529364)
34. Wang XD. Chronic alcohol intake interferes with retinoid metabolism and signaling. Nutr Rev 1999;57:51-59.
35. Liu C, Russell RM, Seitz HK, Wang XD. Ethanol enhances retinoic acid metabolism into polar metabolites in rat liver via induction of cytochrome P4502E1. Gastroenterology 2001;120:179-89. (Pubitemid 32061882)
36. Liu C, Chung J, Seitz HK, Russell RM, Wang XD. Chlormethiazole treatment prevents reduced hepatic vitamin A levels in ethanol-fed rats. Alcohol Clin Exp Res 2002;26:1703-709. (Pubitemid 35439660)
37. Pan Z, Dan Z, Fu Y, Tang W, Lin J. Low-dose ATRA supplementation abolishes PRM formation in rat liver and ameliorates ethanol-induced liver injury. J Huazhong Univ Sci Technolog Med Sci 2006;26:508-12.
38. Easwaran V, Pishvaian M, Salimuddin, Byers S. Cross-regulation of beta-catenin-LEF/TCF and retinoid signaling pathways. Curr Biol 1999;9:1415-18.
39. Zarnegar R. Regulation of HGF and HGFR gene expression. EXS 1995;74:33-49.
40. Saso K, Higashi K, Nomura T, Hoshino M, Ito M, Moehren G, et al. Inhibitory effect of ethanol on hepatocyte growth factor-induced DNA synthesis and Ca2+ mobilization in rat hepatocytes. Alcohol Clin Exp Res 1996;20:330A-34A. (Pubitemid 27009761)
41. Fang JW, Bird GL, Nakamura T, Davis GL, Lau JY. Hepatocyte proliferation as an indicator of outcome in acute alcoholic hepatitis. Lancet 1994;343:820-23. (Pubitemid 24147511)
42. Tahara M, Matsumoto K, Nukiwa T, Nakamura T. Hepatocyte growth factor leads to recovery from alcohol-induced fatty liver in rats. J Clin Invest 1999;103:313-20. (Pubitemid 29069980)
43. Monga SP, Mars WM, Pediaditakis P, Bell A, Mule K, Bowen WC, et al. Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes. Cancer Res 2002;62:2064-71. (Pubitemid 34408453)
44. Saadeddin A, Babaei-Jadidi R, Spencer-Dene B, Nateri AS. The links between transcription, beta-catenin/JNK signaling, and carcinogenesis. Mol Cancer Res 2009;7:1189-196.
45. Wu X, Tu X, Joeng KS, Hilton MJ, Williams DA, Long F. Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling. Cell 2008;133:340-53. (Pubitemid 351508298)
46. Itoh T, Kamiya Y, Okabe M, Tanaka M, Miyajima A. Inducible expression of Wnt genes during adult hepatic stem/progenitor cell response. FEBS Lett 2009;583:777-81.
47. Carmon KS, Loose DS. Secreted frizzled-related protein 4 regulates two Wnt7a signaling pathways and inhibits proliferation in endometrial cancer cells. Mol Cancer Res 2008;6:1017-28.
48. Heasley LE, Winn RA. Analysis of Wnt7a-stimulated JNK activity and cJun phosphorylation in non-small cell lung cancer cells. Methods Mol Biol 2008;468:187-96.
49. Aleksic K, Lackner C, Geigl JB, Schwarz M, Auer M, Ulz P, et al. Evolution of genomic instability in diethylnitrosamine-induced hepatocarcinogenesis in mice. Hepatology 2011;53:895-904.
50. Stahl S, Ittrich C, Marx-Stoelting P, Kohle C, Altug-Teber O, Riess O, et al. Genotype-phenotype relationships in hepatocellular tumors from mice and man. Hepatology 2005;42:353-61. (Pubitemid 41061088)
51. Thakur R, Mishra DP. Pharmacological modulation of beta-catenin and its applications in cancer therapy. J Cell Mol Med 2013;17:449-56.